Dendritic Cell Tumor - 14 Studies Found
Recruiting |
: Selective Depletion of CD45RA+ T Cells From Allogeneic Peripheral Blood Stem Cell Grafts From HLA-Matched Related and Unrelated Donors in Preventing GVHD :
|
Completed |
: MK2206 in Treating Younger Patients With Recurrent or Refractory Solid Tumors or Leukemia :
: |
Active, not recruiting |
: Fludarabine Phosphate and Total-Body Radiation Followed by Donor Peripheral Blood Stem Cell Transplant and Immunosuppression in Treating Patients With Hematologic Malignancies :
|
Active, not recruiting |
: An Open-label Phase II Study of Lorvotuzumab Mertansine : Leukemia : 2015-04-15 : Drug: Lorvotuzumab Mertansine (IMGN901) 100 mg/m2 by vein on Day 1 and 8 of a 21-day cycle. |